Literature DB >> 1320261

Lipolytic action of glucagon-like peptides in isolated rat adipocytes.

C Ruiz-Grande1, C Alarcón, E Mérida, I Valverde.   

Abstract

The lipolytic effect of GLP-1(1-36)-amide, GLP-1(7-36) amide and GLP-2 [proglucagon(126-159)] has been studied in isolated rat adipocytes. Glycerol release and cyclic AMP content were measured after incubation of adipocytes with GLPs and results have been compared with those obtained in the presence of glucagon. GLP-1(7-36)-amide and GLP-1(1-36)-amide at 10(-8), 10(-7) and 10(-6) M concentrations activated glycerol release, the truncated peptide having a more potent effect. On the other hand, GLP-2 had no effect on glycerol release. Also, it has been found that 10(-6) M GLP-1(7-36)-amide increases cyclic AMP content in adipocytes and does not compete with glucagon binding. These results demonstrate that GLP-1(7-36)-amide has a lipolytic effect on isolated rat adipocytes through different receptors than glucagon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320261     DOI: 10.1016/0196-9781(92)90134-o

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  18 in total

1.  Metabolic and endocrine functions of glucagon-like peptides - evolutionary and biochemical perspectives.

Authors:  T P Mommsen; E M Plisetskaya
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

2.  Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas.

Authors:  Teresa Vanessa Fiorentino; Francesca Casiraghi; Alberto M Davalli; Giovanna Finzi; Stefano La Rosa; Paul B Higgins; Gregory A Abrahamian; Alessandro Marando; Fausto Sessa; Carla Perego; Rodolfo Guardado-Mendoza; Subhash Kamath; Andrea Ricotti; Paolo Fiorina; Giuseppe Daniele; Ana M Paez; Francesco Andreozzi; Raul A Bastarrachea; Anthony G Comuzzie; Amalia Gastaldelli; Alberto O Chavez; Eliana S Di Cairano; Patrice Frost; Livio Luzi; Edward J Dick; Glenn A Halff; Ralph A DeFronzo; Franco Folli
Journal:  JCI Insight       Date:  2019-10-17

Review 3.  GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis.

Authors:  Romano Schneider; Marko Kraljević; Ralph Peterli; Theresa V Rohm; Jennifer M Klasen; Claudia Cavelti-Weder; Tarik Delko
Journal:  Obes Surg       Date:  2020-06-05       Impact factor: 4.129

4.  Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.

Authors:  M L Villanueva-Peñacarrillo; J Puente; A Redondo; F Clemente; I Valverde
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

5.  GLP-1 does not not acutely affect insulin sensitivity in healthy man.

Authors:  L Orskov; J J Holst; J Møller; C Orskov; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

6.  [Incretins: do they exert cardiovascular effects?].

Authors:  Baptist Gallwitz
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

Review 7.  Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies.

Authors:  Janine J Geerling; Mariëtte R Boon; Sander Kooijman; Edwin T Parlevliet; Louis M Havekes; Johannes A Romijn; Illiana M Meurs; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2013-11-27       Impact factor: 5.922

8.  GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

Authors:  Camila Puzzi de Carvalho; Daniela Miguel Marin; Aglécio Luiz de Souza; José Carlos Pareja; Elintom Adami Chaim; Silvia de Barros Mazon; Conceição Aparecida da Silva; Bruno Geloneze; Elza Muscelli; Sarah Monte Alegre
Journal:  Obes Surg       Date:  2008-09-25       Impact factor: 4.129

9.  Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.

Authors:  Rajaa El Bekay; Leticia Coín-Aragüez; Diego Fernández-García; Wilfredo Oliva-Olivera; Rosa Bernal-López; Mercedes Clemente-Postigo; Javier Delgado-Lista; Alberto Diaz-Ruiz; Rocío Guzman-Ruiz; Rafael Vázquez-Martínez; Said Lhamyani; María Mar Roca-Rodríguez; Sonia Fernandez Veledo; Joan Vendrell; María M Malagón; Francisco José Tinahones
Journal:  Br J Pharmacol       Date:  2016-04-28       Impact factor: 8.739

Review 10.  GLP-1: benefits beyond pancreas.

Authors:  G Muscogiuri; A Cignarelli; F Giorgino; F Prodam; F Prodram; D Santi; G Tirabassi; G Balercia; R Modica; A Faggiano; A Colao
Journal:  J Endocrinol Invest       Date:  2014-08-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.